Welcome to our dedicated page for DALRADA FINCL news (Ticker: DFCO), a resource for investors and traders seeking the latest updates and insights on DALRADA FINCL stock.
Dalrada Financial Corporation, through its subsidiaries, provides various products and services in the manufacturing, engineering, and healthcare sectors worldwide. The company offers low-carbon heating and cooling systems, visual inspection kits for detecting cervical cancer, and software solutions in test engineering, accessibility engineering, and more. Additionally, it provides cleaning solutions with electrostatic machines for various facilities. Formerly known as Imaging Technologies Corporation, Dalrada Financial Corporation was incorporated in 1982 and is headquartered in Escondido, California.
The company, under the leadership of CEO Brian Bonar, focuses on driving innovation in the Clean Energy and Health Care sectors. Its segments include Dalrada Climate Technology and Genefic Specialty Pharmacy, offering advanced heat pump technology and end-to-end prescription services, respectively. With a commitment to sustainability and cutting-edge solutions, Dalrada Financial Corporation aims to deliver value to its shareholders.
Dalrada Corporation (OTCQB: DFCO) has announced the opening of two new subsidiaries under Dalrada Health. Pala Diagnostics is a national laboratory for COVID-19 testing, providing rapid antigen and PCR testing, while Sòlas Rejuvenation + Wellness offers advanced wellness programs. CEO Brian Bonar emphasized the importance of accurate health testing amidst the ongoing health crisis, highlighting Pala’s CLIA-certified lab's rapid results and mobile services. Dalrada Health aims to improve global health accessibility and affordability.
Dalrada Corporation (OTCQB: DFCO) has announced a joint venture between its subsidiary Dalrada Health and Vivera Pharmaceutical, Inc., creating Pala Diagnostics, LLC. This initiative aims to enhance COVID-19 testing capabilities, providing rapid results and life science testing services. Pala Diagnostics will initially offer EUA-approved rapid antigen tests and lab-based PCR testing. The collaboration seeks to support businesses and educational institutions as they reopen safely. The venture taps into Vivera's extensive healthcare network and expertise in pharmaceuticals and diagnostics.
Dalrada Corporation (OTCQB: DFCO) has appointed The Honorable Bijan R. Kian, Jose Arrieta, and Kyle McCollum to its Board of Directors. CEO Brian Bonar expressed enthusiasm for these appointments, highlighting their extensive experience in global trade, technology, and finance, which will enhance the company's initiatives in engineering, health, and clean energy. The new board members aim to accelerate Dalrada’s growth and innovation across its diverse sectors. With a commitment to disruptive solutions, Dalrada continues to strive for accessibility and positive change globally.
Dalrada Corporation (DFCO) announces its subsidiary, Dalrada Precision, has entered the eco-friendly degreaser market with Ignite Industrial Technologies’ products. These biodegradable cleaners offer a safer and more effective solution for manufacturing efficiency. The global cleaner and degreaser market is expected to grow, with the aftermarket projected to reach USD 42.63 billion by 2026. Ignite products are designed to be environmentally friendly, non-toxic, and effective for various industrial applications. This innovation positions Dalrada to capitalize on the increasing demand for sustainable cleaning solutions.
Dalrada Corporation (DFCO) announces a strategic partnership between its IT engineering subsidiary, Prakat Solutions, and ValueQwest Pte. Ltd. to enhance the digital transformation of global supply chains. A report indicates a substantial growth in the digital transformation market, predicting logistics spending to reach $75.5 billion by 2026, growing at a CAGR of 8.8%. This collaboration aims to develop scalable solutions and a talent pool of specialists in supply chain technologies, benefiting clients across 17 countries, including major firms like Microsoft and Oracle.
Dalrada Corporation (OTCQB: DFCO) has announced the appointment of Dr. David Bacon to its Board of Directors. Dr. Bacon brings over 22 years of active Navy experience and has been instrumental in evaluating funding proposals during the SARS-CoV-2 pandemic. His extensive background includes key roles in various defense-related health programs and significant scientific contributions, including 35 peer-reviewed publications. CEO Brian Bonar stated that Dr. Bacon’s expertise will enhance Dalrada Health's product development. The Board now comprises leaders from various sectors, focusing on innovative health and sustainability solutions.
Dalrada Corporation (OTCQB: DFCO) announced that its Technology Company, Prakat Solutions Inc., will sponsor the annual Global Accessibility Awareness Day (GAAD) event focused on digital inclusivity. This virtual event, starting on May 20th and spanning four days, will feature industry leaders and experts discussing accessibility challenges for users with disabilities. Prakat's initiative aims to improve digital experiences for over 1 billion individuals worldwide.
The event highlights Prakat's commitment to accessibility engineering and compliance with standards like the ADA and W3C.
Dalrada Corporation (DFCO) reported third-quarter financial results for fiscal year 2021, showing a remarkable 352% increase in revenues to $1,588,329, compared to $351,324 in Q3 2020. This quarter marks the company's top performance since its strategic shift in 2018. However, gross profit decreased to 46% from 57% in the previous quarter, attributed to rising raw material costs and investments in new subsidiaries. The company continues to expand its operations globally while focusing on sustainable solutions in healthcare and technology.
Dalrada Corporation (OTCQB: DFCO) announces the appointment of Mr. Kyle McCollum as Chief Financial Officer. With nearly 20 years of expertise in finance and business management, McCollum's background includes roles in investment strategy and compliance. CEO Brian Bonar highlighted that McCollum's experience will be crucial for Dalrada's global expansion. McCollum holds degrees in accounting from the University of Montana and has overseen operations in various industries, ranging from real estate to nutraceuticals. The company aims for robust growth through innovative solutions.
Dalrada Corporation (OTCQB: DFCO) announces the launch of its subsidiary, Dalrada Health’s Empower Genomics, offering a suite of genomics tests including Pharmacogenomics, Cannabis DNA, Nutrition & Diet, and Exercise & Fitness. This service enables healthcare practitioners and individuals to enhance well-being through genetic insights. The global genomics market is projected to grow from USD 22.7 billion in 2020 to USD 54.4 billion by 2025, indicating a significant opportunity for Dalrada. Empower Genomics utilizes HIPAA-compliant technology to ensure secure processing of genetic tests.
FAQ
What is the current stock price of DALRADA FINCL (DFCO)?
What is the market cap of DALRADA FINCL (DFCO)?
What products and services does Dalrada Financial Corporation offer?
When was Dalrada Financial Corporation incorporated?
Where is Dalrada Financial Corporation headquartered?
Who is the CEO of Dalrada Financial Corporation?
What are the core segments of Dalrada Financial Corporation?
What is the focus of Dalrada Financial Corporation?
What is the mission of Dalrada Financial Corporation?
